Experienced in Infectious Arthritis

Dong Y. Ma

Guangzhou, CN 
Experienced in Infectious Arthritis
Guangzhou, CN 
OverviewLocationsClinical Research

Overview

Dong Ma practices in Guangzhou, China. Mr. Ma is rated as an Experienced expert by MediFind in the treatment of Infectious Arthritis. His top areas of expertise are Hemolysis, Methicillin-Resistant Staphylococcus Aureus (MRSA), Infectious Arthritis, and Septic Arthritis.

His clinical research consists of co-authoring 57 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles in the study of Infectious Arthritis.

Gender
Male

Locations

Guangzhou, 510630, China
Other Locations
Guangdong Provincial Key Laboratory Of Spine And Spinal Cord Reconstruction, Heyuan, 517000, China
China
Hefei, 230031, China
Cangzhou, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Clinical Study Comparing the Efficacy and Safety of Tislelizumab (BGB-A317) Plus Platinum and Fluoropyrimidine Versus Placebo Plus Platinum and Fluoropyrimidine as First-Line Treatment in Patients With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Clinical Study Comparing the Efficacy and Safety of Tislelizumab (BGB-A317) Plus Platinum and Fluoropyrimidine Versus Placebo Plus Platinum and Fluoropyrimidine as First-Line Treatment in Patients With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
Enrollment Status: Completed
Publish Date: February 14, 2025
Intervention Type: Drug
Study Phase: Phase 3

57 Total Publications

Corrigendum to "High molecular weight hyaluronic acid-liposome delivery system for efficient transdermal treatment of acute and chronic skin photodamage" [Acta Biomaterialia 182, 2024, 171-187].
Corrigendum to "High molecular weight hyaluronic acid-liposome delivery system for efficient transdermal treatment of acute and chronic skin photodamage" [Acta Biomaterialia 182, 2024, 171-187].
Journal: Acta biomaterialia
Published: November 11, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Ma's expertise for a condition
ConditionClose
        View All 14 Experienced Conditions
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile